Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisatracurium pretreatment for succinylcholine-induced fasciculations
NCT02481193Phase 3Completed
- Sponsor
- Yangzhou First People's Hospital
- Start
- Mar 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cisatracurium in fasciculation, myalgia, sponsored by Yangzhou First People's Hospital. Started Mar 2013; status: completed.
02
Drugs
cisatracurium
03
Conditions
fasciculationmyalgia
Beyond the preview
Go deeper on NCT02481193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02481193.